Ledipasvir + sofosbuvir

Trade Name:

Harvoni

Manufacturer/Distributor:

Gilead Sciences Canada Inc.

www.gilead.ca

(905) 363-8008

Classification:

Antiviral agent

ATC Class:

J05AX - Other Antivirals

Status:

active

Notice of Compliance (yyyy/mm/dd):

2014/10/15

Date Marketed in Canada (yyyy/mm/dd):

2015/01/07

Presentation:

Tablet: ledipasvir 90 mg + sofosbuvir 400 mg. DIN: 02432226

Comments:

Harvoni, an antiviral agent, is used for the treatment of chronic hepatitis C virus HCV genotype 1 infection in adults. The safety and efficacy of Harvoni have not been established in patients with decompensated cirrhosis, or in pediatric patients. Treatment with Harvoni should be initiated and monitored by a physician experienced in the management of CHC. To enrol Harvoni patients in the Gilead Momentum Support Program, fax a completed enrolment form to 1-855-505-5885 or enrol via the Gilead Momentum Support Program online at www.gileadmomentum.com.

Keywords:

hepatitis c

Keywords:

ledipasvir

Keywords:

sofosbuvir

Access:

public

Back to:

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database

A (37) | B (20) | C (24) | D (37) | E (40) | F (12) | G (11) | H (9) | I (24) | K (1) | L (26) | M (12) | N (7) | O (12) | P (28) | R (14) | S (27) | T (33) | U (4) | V (13) | W (2) | Z (4)

Generic Name	Common Trade Name(s)	Classification	Date Marketed in Canada (yyyy/mm/dd)
Zucapsaicin	Zuacta	Topical agent for joint and muscular pain	2011/08/24
Influenza vaccine	Fluad	Influenza vaccine	2011/08/25
Pazopanib	Votrient	Antineoplastic agent	2011/08/25
Vardenafil	Staxyn	Phosphodiesterase Type 5 Inhibitor	2011/08/29
Rufinamide	Banzel	Antiepileptic	2011/09
Linagliptin	Trajenta	Oral antihyperglycemic agent	2011/09/13
Tolvaptan	Samsca	Vasopressin V2 receptor antagonist	2011/09/22
Risedronate	Actonel DR	Bone metabolism regulator	2011/09/28
Belimumab	Benlysta	Immunosuppressant	2011/10/01
Ketorolac tromethamine	Acuvail	Topical NSAID	2011/10/01
Denosumab	Xgeva	Bone resorption inhibitor	2011/10/05
Telaprevir	Incivek	Antiviral agent	2011/10/06
Dapsone	Aczone	Anti-acne therapy	2011/10/21
Drotrecogin alfa	Xigris	Antithrombotic profibrinolytic anti-inflammatory enzyme	2011/10/25
Indomethacin	Indomethacin P.D.A.	NSAID	2011/11/15
Dienogest	Visanne	Progestin	2011/12/
Digoxin Immune Fab (Ovine)	Digifab	Antidote	2011/12/09
Mometasone	Asmanex Twisthaler	Corticosteroid	2011/12/22
Estradiol	Vagifem	Hormone replacement therapy	2011/12/31
Oxycodone	OxyNEO	Narcotic	2012/01/01
Doxepin	Silenor	Hypnotic	2012/01/08
Prucalopride	Resotran	Enterokinetic agent	2012/01/13
Dimeticone	Nyda	Pediculocide	2012/01/17
Dexamethasone	Ozurdex	Corticosteroid	2012/01/19
Vandetanib	Caprelsa	Receptor tyrosine kinase inhibitor (antineoplastic agent)	2012/01/24
Plerixafor	Mozobil	Hematopoietic agent	2012/01/26
Vemurafenib	Zelboraf	Antineoplastic agent	2012/02
Dutasteride + tamsulosin	Jalyn	Alpha-1 blocker + 5-Alpha reductase inhibitor	2012/02/03
Tamsulosin + dutasteride	Jalyn	Alpha-1 blocker + 5-Alpha reductase inhibitor	2012/02/03
Pancrelipase	Cotazym ECS 4 & Cotazym 65B	Pancreatic enzymes	2012/02/06
Colesevelam	Lodalis	Bile acid sequestrant	2012/02/06
Dronabinol	Marinol	Antiemetic	2012/02/24
Flumazenil	Anexate	Benzodiazepine antagonist	2012/02/28
Oxycodone	OxyContin	Narcotic	2012/02/29
Apixaban	Eliquis	Anticoagulant	2012/03
Ipilimumab	Yervoy	Antineoplastic agent	2012/03